SynthesisPloS one2015

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis.

Ning Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.